Jean Jacques Bienaime, Director at Immunome Inc. (IMNM), bought 2,000 shares at $22.12 ($44K) on 2026-03-10, disclosed to the SEC on 2026-03-12.
Open-market purchase of $44k IMNM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.12 | 1,000 | $22K | 50.7% |
| 2 | $21.55 | 1,000 | $22K | 49.3% |
| Total | $21.84 avg | 2,000 | $44K | 100% |
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |